Data Science Funding Announcements & Notices
Data science and informatics funding announcements and notices are available from NCI and NIH programs. Browse below for opportunities, requests for information, notices, and initiatives.
| Title | FOA | Organization | Release Date | Expire Date Sort ascending | Purpose |
|---|---|---|---|---|---|
| Understanding Mechanisms and Outcomes of Trained Immunity (R21 Clinical Trial Not Allowed) | PAR-24-111 | NIAID | The purpose of this Notice of Funding Opportunity (NOFO) is to support research that improves understanding of basic mechanisms and biomarkers of trained immunity (i.e., innate immune memory), plus… More | ||
| Understanding Mechanisms and Outcomes of Trained Immunity (R01 Clinical Trial Not Allowed) | PAR-24-112 | NIAID | The purpose of this Notice of Funding Opportunity (NOFO) is to support research that improves understanding of basic mechanisms and biomarkers of trained immunity (i.e., innate immune memory), plus… More | ||
| Discovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowed) | PAR-24-088 | NIMH | The purpose of this Notice of Funding Opportunities (NOFOs) is to support investigators who have interest and capability to join efforts for the discovery of in vivo chemical probes for novel brain… More | ||
| NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) | PA-24-141 | NIH | The purpose of the NIH Research Conference Grant (R13) is to support high quality conferences that are relevant to the public health and to the scientific mission of the participating Institutes and… More | ||
| NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required) | PAR-24-172 | NHLBI | The objective of this funding opportunity is to support investigator-initiated, phase I clinical trials for diagnostic and therapeutic interventions for heart, lung, blood, and sleep (HLBS) disorders… More | ||
| NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required) | PAR-24-173 | NHLBI | The objective of this funding opportunity is to support investigator-initiated, Phase I clinical trials for diagnostic and therapeutic interventions for heart, lung, blood, and sleep (HLBS) disorders… More | ||
| Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed) | PAR-24-144 | NIGMS | The SuRE program supports research capacity building at eligible higher education institutions bythrough funding investigator-initiated biomedical research inbasic, social, clinical, behavioral, or… More | ||
| Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed) | PAR-24-145 | NIGMS | The SuRE program supports research capacity building at eligible higher education institutions through funding investigator-initiated biomedical research inbasic, social, clinical, behavioral, or… More | ||
| Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional) | PAR-23-259 | NCI | Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to stimulate translation of scientific discoveries and engineering developments in imaging, data science… More | ||
| Notice of Special Interest (NOSI):?Advancing Data Science Research in HIV: Responding to a Dynamic, Complex, and Evolving HIV Epidemic with Artificial Intelligence/Machine Learning | NOT-MH-23-350 | NIMH | This NOFO seeks to advance data science research in HIV using cutting edge synthetic data, artificial intelligence and machine learning (AI/ML) approaches to expand our capacity to address the… More |